Millennium Management’s Autolus Therapeutics AUTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$283K Buy
+204,728
New +$311K ﹤0.01% 5033
2025
Q4
Sell
-391,833
Closed -$639K 6021
2025
Q3
$639K Buy
+391,833
New +$765K ﹤0.01% 4927
2025
Q2
Sell
-1,986,190
Closed -$3.08M 5866
2025
Q1
$3.08M Buy
1,986,190
+332,949
+20% +$676K ﹤0.01% 3364
2024
Q4
$3.89M Buy
1,653,241
+790,437
+92% +$2.67M ﹤0.01% 3054
2024
Q3
$3.13M Buy
862,804
+49,773
+6% +$198K ﹤0.01% 3258
2024
Q2
$2.83M Buy
813,031
+432,503
+114% +$1.87M ﹤0.01% 3221
2024
Q1
$2.43M Buy
380,528
+319,798
+527% +$1.99M ﹤0.01% 3562
2023
Q4
$391K Buy
+60,730
New +$232K ﹤0.01% 4796
2023
Q2
Sell
-360,145
Closed -$663K 6117
2023
Q1
$663K Buy
360,145
+234,495
+187% +$458K ﹤0.01% 4426
2022
Q4
$239K Buy
125,650
+46,640
+59% +$118K ﹤0.01% 5227
2022
Q3
$169K Sell
79,010
-158,649
-67% -$470K ﹤0.01% 5750
2022
Q2
$673K Buy
237,659
+70,093
+42% +$213K ﹤0.01% 4720
2022
Q1
$699K Sell
167,566
-142,758
-46% -$600K ﹤0.01% 4860
2021
Q4
$1.61M Sell
310,324
-133,107
-30% -$799K ﹤0.01% 3963
2021
Q3
$2.9M Sell
443,431
-281,741
-39% -$1.78M ﹤0.01% 3472
2021
Q2
$4.82M Buy
725,172
+496,663
+217% +$3.08M 0.01% 2809
2021
Q1
$1.31M Buy
228,509
+197,636
+640% +$1.46M ﹤0.01% 3941
2020
Q4
$276K Sell
30,873
-117,447
-79% -$1.25M ﹤0.01% 4606
2020
Q3
$1.73K Sell
148,320
-578,521
-80% -$8.39M ﹤0.01% 2711
2020
Q2
$11.7M Sell
726,841
-56,323
-7% -$625K 0.03% 1115
2020
Q1
$4.69M Buy
783,164
+106,683
+16% +$986K 0.02% 1376
2019
Q4
$8.93M Sell
676,481
-719,661
-52% -$9.42M 0.02% 1467
2019
Q3
$17.3M Buy
1,396,142
+628,306
+82% +$8.3M 0.04% 878
2019
Q2
$12.4M Buy
767,836
+317,474
+70% +$7.1M 0.02% 1100
2019
Q1
$14.2M Buy
450,362
+438,662
+3,749% +$12.5M 0.03% 1025
2018
Q4
$384K Sell
11,700
-24,258
-67% -$798K ﹤0.01% 3107
2018
Q3
$1.08M Sell
35,958
-109,987
-75% -$2.97M ﹤0.01% 2831
2018
Q2
$3.91M Buy
+145,945
New +$3.86M 0.01% 1962

Other funds holding AUTL